Updates are available Correction dated 2025-03-11
Click to view Correction: https://doi.org/10.1007/s10620-025-08961-9
-
Authors
Young, Graeme P.
Benton, Sally C.
Bresalier, Robert S.
Chiu, Han-Mo
Dekker, Evelien
Fraser, Callum G.
Frasa, Marieke A. M.
Halloran, Stephen P.
Hoffmeister, Michael
Parry, Susan
Selby, Kevin
Senore, Carlo
Singh, Harminder
Symonds, Erin L.
-
Funding
Funding for this research was provided by:
Flinders University
- License Information
-
More Information
Article History
Received: 2 September 2024
Accepted: 23 September 2024
First Online: 11 November 2024
Change Date: 5 March 2025
Change Type: Update
Change Details: The original online version of this article was revised: The error in Figure 1 has been corrected.
Change Date: 11 March 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10620-025-08961-9
Declarations
:
: Graeme P Young: Consultancy—Health First Systems, Institutional research support–Eiken Chemical Company. Han-Mo Chiu: Speaker honorarium—Olympus, Fujifilm, Boston Scientific, Research funding—Boston Scientific, Volition Rx, aether AI. Evelien Dekker: Institutional research support—FujiFilm. Consultancy—Olympus, Fujifilm, Ambu, InterVenn, Norgine, and Exact Sciences. Speaker’s fees—Olympus, GI Supply, Norgine, IPSEN/Mayoly, and FujiFilm. Harminder Singh: COI: Consultancy/advisory boards—Abbvie Canada, Amgen Canada, Roche Canada, Sandoz Canada, Organon Canada, Eli Lilly Canada, Takeda Canada, Pendopharm Inc, and Guardant Health, Inc. Institutional research support—Pfizer. Shares—VasCon. Erin L Symonds: Institutional research support—Eiken Chemical Company and Health First Systems. The authors declare no competing interests, and no financial arrangements related to the research or assistance with manuscript preparation.
